T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Amazon
AMZN
|
+$3.55B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.02B |
| 3 |
EQT Corp
EQT
|
+$1.52B |
| 4 |
Adobe
ADBE
|
+$1.29B |
| 5 |
Constellation Energy
CEG
|
+$1.16B |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.09B |
| 2 |
UnitedHealth
UNH
|
+$1.75B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.69B |
| 4 |
Ross Stores
ROST
|
+$1.64B |
| 5 |
ASML
ASML
|
+$1.59B |
Sector Composition
| 1 | Technology | 31.66% |
| 2 | Healthcare | 16.93% |
| 3 | Consumer Discretionary | 11.06% |
| 4 | Financials | 10.59% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
BioMarin Pharmaceuticals
BMRN
$10.7B
| $112M | 0.02% |
1,291,678
-2,369
| -0.2% | -$205K |
|
502
Packaging Corp of America
PKG
$19.4B
| $112M | 0.02% |
844,707
-169,031
| -17% | -$22.3M |
|
503
XP
XP
$9.76B
| $110M | 0.02% |
4,681,580
-5,769,510
| -55% | -$135M |
|
504
Vaxcyte
PCVX
$4.21B
| $109M | 0.02% |
2,192,382
+2,160,354
| +6,745% | +$108M |
|
505
Carlyle Group
CG
$23.2B
| $109M | 0.02% |
3,414,374
+358,317
| +12% | +$11.4M |
|
506
Banco Santander Chile
BSAC
$11.9B
| $108M | 0.02% |
5,754,042
-126,358
| -2% | -$2.38M |
|
507
Vornado Realty Trust
VNO
$7.81B
| $107M | 0.01% |
5,889,182
+1,426,192
| +32% | +$25.9M |
|
508
NovoCure
NVCR
$1.42B
| $106M | 0.01% |
2,545,465
-110,221
| -4% | -$4.57M |
|
509
Gartner
IT
$18.7B
| $105M | 0.01% |
301,080
+4,181
| +1% | +$1.46M |
|
|
CTLT
510
DELISTED
CATALENT, INC.
CTLT
| $105M | 0.01% |
2,424,065
+646,674
| +36% | +$28M |
|
|
WWE
511
DELISTED
World Wrestling Entertainment
WWE
| $105M | 0.01% |
968,565
+302,166
| +45% | +$32.8M |
|
512
Relay Therapeutics
RLAY
$702M
| $105M | 0.01% |
8,345,517
+1,482,557
| +22% | +$18.6M |
|
513
Wynn Resorts
WYNN
$12.8B
| $105M | 0.01% |
991,829
-4,993,934
| -83% | -$527M |
|
514
Paychex
PAYX
$48.7B
| $105M | 0.01% |
936,298
-1,286
| -0.1% | -$144K |
|
515
Idexx Laboratories
IDXX
$52.2B
| $104M | 0.01% |
208,020
+34,108
| +20% | +$17.1M |
|
516
Inspire Medical Systems
INSP
$2.47B
| $103M | 0.01% |
317,120
+23,925
| +8% | +$7.77M |
|
517
Acadia Realty Trust
AKR
$2.54B
| $103M | 0.01% |
7,123,798
+279,187
| +4% | +$4.02M |
|
518
News Corp Class B
NWS
$19.1B
| $102M | 0.01% |
5,185,697
+443,121
| +9% | +$8.74M |
|
519
Denali Therapeutics
DNLI
$2.25B
| $102M | 0.01% |
3,445,312
-92,466
| -3% | -$2.73M |
|
520
Churchill Downs
CHDN
$6.85B
| $101M | 0.01% |
726,489
+21,315
| +3% | +$2.97M |
|
521
PayPal
PYPL
$64.7B
| $101M | 0.01% |
1,508,978
-26,610
| -2% | -$1.78M |
|
522
Duke Energy
DUK
$93.4B
| $100M | 0.01% |
1,119,370
+450
| +0% | +$40.4K |
|
523
MarketAxess Holdings
MKTX
$6.99B
| $99.2M | 0.01% |
379,335
+5,295
| +1% | +$1.38M |
|
524
Emerson Electric
EMR
$74.7B
| $99.2M | 0.01% |
1,096,982
-1,773,060
| -62% | -$160M |
|
525
MoonLake Immunotherapeutics
MLTX
$3.88B
| $99.1M | 0.01% |
1,943,056
+1,112,150
| +134% | +$56.7M |
|